Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Leukemia · Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Lymphoma · Chronic Myelogenous Leukemia · Plasma Cell Leukemia · Myeloproliferative Neoplasms · Myelofibrosis · Myelodysplasia · Refractory Anemia · High Risk Anemia · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Marginal Zone B-Cell Lymphoma · Follicular Lymphoma · Lymphoplasmacytic Lymphoma · Mantle-Cell Lymphoma · Prolymphocytic Leukemia · Diffuse Large Cell Non Hodgkins Lymphoma · Lymphoblastic Lymphoma · Burkitt Lymphoma · High Grade Non-Hodgkin's Lymphoma, Adult · Multiple Myeloma · Juvenile Myelomonocytic Leukemia · Biphenotypic/Undifferentiated/Prolymphocytic Leukemias · MRD Positive Leukemia · Natural Killer Cell Malignancies · Acquired Bone Marrow Failure Syndromes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Tamy Grainger, RN) · tgraing1@fairview.org · 612-273-2800
Study leads
  • Punita Grover, MD

    Principal Investigator

    Masonic Cancer Center, University of Minnesota